|1.||Pinsky, Michael R: 3 articles (10/2015 - 07/2002)|
|2.||Landoni, Giovanni: 3 articles (09/2013 - 10/2009)|
|3.||Tobe, Yoshitsugu: 3 articles (06/2012 - 04/2010)|
|4.||Nishikawa, Toshiaki: 3 articles (06/2012 - 04/2010)|
|5.||Goyagi, Toru: 3 articles (06/2012 - 04/2010)|
|6.||Takeda, Shohei: 3 articles (03/2011 - 04/2004)|
|7.||Adamson, Peter C: 3 articles (08/2008 - 11/2003)|
|8.||Geissler, H J: 3 articles (12/2002 - 01/2000)|
|9.||Wu, Qinghua: 2 articles (01/2016 - 11/2015)|
|10.||Nie, Xiangbi: 2 articles (01/2016 - 11/2015)|
01/01/2013 - "The early effect of esmolol on exercise-induced tachycardia was significantly greater among Arg389 than in Gly389 homozygote healthy individuals (NCT01388036)."
02/01/1994 - "Esmolol, an ultrashort-acting beta-adrenergic blocking agent, has been reported in western published reports to have good results and few side effects in the treatment of supraventricular tachyarrhythmia. "
03/01/1991 - "A double-blind, randomised study was conducted to examine the efficacy of a single bolus dose of esmolol in treating surgically-induced tachycardia. "
07/01/1990 - "A randomized, double-blind, parallel, placebo-controlled study was conducted to determine the safety and efficacy of intravenous (IV) bolus administration of esmolol in treating intraoperative tachycardia in patients undergoing noncardiac general surgery. "
08/01/1988 - "This study supports previous observations concerning the safety and efficacy of esmolol in the treatment of supraventricular tachyarrhythmias. "
|2.||Hypertension (High Blood Pressure)
06/01/2012 - "Esmolol was effective in controlling hypertension following cardiac surgery and terminating supraventricular arrhythmias in children. "
08/01/2008 - "The primary objective of this phase IIIb, multicenter, double-blind, randomized, dose-ranging trial was the efficacy of esmolol to control hypertension. "
07/01/2006 - "Esmolol is often used in the acute management of children with arrhythmias and/or hypertension; however, pharmacokinetic studies of the drug in children have been limited. "
04/01/1998 - "Twenty patients aged 1 month to 12 years (median 25.6 months) with acute hypertension after cardiac operations received esmolol in an opened-labeled trial. "
11/01/1994 - "In this study, the effect of the new, short-acting beta-blocker esmolol given as a single bolus for preventing the increases in blood pressure and heart rate during recovery from anaesthesia and extubation in patients with hypertension was investigated. "
|3.||Myocardial Ischemia (Ischemic Heart Diseases)
04/01/2010 - "The use of esmolol was associated with a significant reduction of myocardial ischemia episodes (5/283 [1.76%] in the esmolol group v 16/265 [6.03%] in the control arm, odds ratio [OR] = 0.16 [0.05-0.54], p = 0.003). "
12/01/2004 - "The present case suggests that esmolol can be used effectively and safely to distinguish CLBBB as a benign disorder from myocardial ischemia in a patient with CLBBB."
10/23/1985 - "Experimental and clinical observations on the efficacy of esmolol in myocardial ischemia."
02/01/2011 - "In comparison with placebo, esmolol decreased the frequency of myocardial ischemia in the 7 evaluating studies (OR 0.17; 95% CI, 0.02 to 0.45). "
07/01/2003 - "Four different criteria for an ischemic event found in our survey were applied to Holter recordings from 66 patients with acute ischemic syndrome enrolled in the Esmolol Myocardial Ischemia Trial (EMIT). "
06/15/1991 - "Thus, esmolol appears to be a safe and effective drug for patients with unstable angina because it permits a large degree of flexibility in adapting the desired level of beta blockade to the patient's changing clinical presentation."
11/15/1988 - "Safety and efficacy of esmolol for unstable angina pectoris."
06/15/1991 - "Usefulness of esmolol in unstable angina pectoris. "
03/01/1991 - "To assess the efficacy and safety of the ultra short-acting beta-blocking agent, esmolol, in acute unstable angina, we administered esmolol to 21 patients who had persistent angina despite conventional medical therapy. "
01/01/1988 - "In patients with myocardial ischemic conditions (acute myocardial infarction and unstable angina), esmolol was safe and produced clinically significant reductions in HR and rate-pressure product. "
01/01/2015 - "Esmolol for tight heart rate control in patients with STEMI: Design and rationale of the beta-blocker in acute myocardial infarction (BEAT-AMI) trial."
09/10/2013 - "In conclusion, the findings of this study may indicate an anti-arrhythmic effect of endogenous neurokinin mechanism, through the activation of which, via up-regulation of NK1 receptor, esmolol may exert its anti-arrhythmic action at the early time of acute myocardial infarction. "
11/01/2007 - "Esmolol facilitated extubation in a patient with severe systolic dysfunction following myocardial infarction."
01/01/2005 - "[The use of esmolol in patients with myocardial infarction complicated with acute left ventricular failure]."
07/01/2003 - "Effect of esmolol on oxidant status and antioxidant activity in acute myocardial infarction."
|2.||Nitroprusside (Sodium Nitroprusside)
|10.||Adrenergic Antagonists (Antiadrenergic Agents)
|2.||Cardiopulmonary Bypass (Heart-Lung Bypass)